Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression

© 2020 American Association for Cancer Research. Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate and lacks effective therapeutics. Therefore, it is of paramount importance to identify new targets. Using multiplex data from patient tissue, three-dimensional coculturing in vitr...

Full description

Bibliographic Details
Main Authors: Francescone, Ralph, Barbosa Vendramini-Costa, Débora, Franco-Barraza, Janusz, Wagner, Jessica, Muir, Alexander, Lau, Allison N., Gabitova, Linara, Pazina, Tatiana, Gupta, Sapna, Luong, Tiffany, Rollins, Dustin, Malik, Ruchi, Thapa, Roshan J., Restifo, Diana, Zhou, Yan, Cai, Kathy Q., Hensley, Harvey H., Tan, Yinfei, Kruger, Warren D., Devarajan, Karthik, Balachandran, Siddharth, Klein-Szanto, Andres J., Wang, Huamin, El-Deiry, Wafik S., Vander Heiden, Matthew G., Peri, Suraj, Campbell, Kerry S., Astsaturov, Igor, Cukierman, Edna
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Language:English
Published: American Association for Cancer Research (AACR) 2022
Online Access:https://hdl.handle.net/1721.1/136086.2
_version_ 1811076387731144704
author Francescone, Ralph
Barbosa Vendramini-Costa, Débora
Franco-Barraza, Janusz
Wagner, Jessica
Muir, Alexander
Lau, Allison N.
Gabitova, Linara
Pazina, Tatiana
Gupta, Sapna
Luong, Tiffany
Rollins, Dustin
Malik, Ruchi
Thapa, Roshan J.
Restifo, Diana
Zhou, Yan
Cai, Kathy Q.
Hensley, Harvey H.
Tan, Yinfei
Kruger, Warren D.
Devarajan, Karthik
Balachandran, Siddharth
Klein-Szanto, Andres J.
Wang, Huamin
El-Deiry, Wafik S.
Vander Heiden, Matthew G.
Peri, Suraj
Campbell, Kerry S.
Astsaturov, Igor
Cukierman, Edna
author2 Koch Institute for Integrative Cancer Research at MIT
author_facet Koch Institute for Integrative Cancer Research at MIT
Francescone, Ralph
Barbosa Vendramini-Costa, Débora
Franco-Barraza, Janusz
Wagner, Jessica
Muir, Alexander
Lau, Allison N.
Gabitova, Linara
Pazina, Tatiana
Gupta, Sapna
Luong, Tiffany
Rollins, Dustin
Malik, Ruchi
Thapa, Roshan J.
Restifo, Diana
Zhou, Yan
Cai, Kathy Q.
Hensley, Harvey H.
Tan, Yinfei
Kruger, Warren D.
Devarajan, Karthik
Balachandran, Siddharth
Klein-Szanto, Andres J.
Wang, Huamin
El-Deiry, Wafik S.
Vander Heiden, Matthew G.
Peri, Suraj
Campbell, Kerry S.
Astsaturov, Igor
Cukierman, Edna
author_sort Francescone, Ralph
collection MIT
description © 2020 American Association for Cancer Research. Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate and lacks effective therapeutics. Therefore, it is of paramount importance to identify new targets. Using multiplex data from patient tissue, three-dimensional coculturing in vitro assays, and orthotopic murine models, we identified Netrin G1 (NetG1) as a promoter of PDAC tumorigenesis. We found that NetG1+ cancer-associated fibroblasts (CAF) support PDAC survival, through a NetG1-mediated effect on glutamate/glutamine metabolism. Also, NetG1+ CAFs are intrinsically immunosup-pressive and inhibit natural killer cell–mediated killing of tumor cells. These protumor functions are controlled by a signaling circuit downstream of NetG1, which is comprised of AKT/4E-BP1, p38/FRA1, vesicular glutamate transporter 1, and glutamine synthetase. Finally, blocking NetG1 with a neutral-izing antibody stunts in vivo tumorigenesis, suggesting NetG1 as potential target in PDAC. SIGNIFICANCE: This study demonstrates the feasibility of targeting a fibroblastic protein, NetG1, which can limit PDAC tumorigenesis in vivo by reverting the protumorigenic properties of CAFs. Moreover, inhibition of metabolic proteins in CAFs altered their immunosuppressive capacity, linking metabolism with immunomodulatory function.
first_indexed 2024-09-23T10:20:39Z
format Article
id mit-1721.1/136086.2
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T10:20:39Z
publishDate 2022
publisher American Association for Cancer Research (AACR)
record_format dspace
spelling mit-1721.1/136086.22024-06-07T17:48:37Z Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression Francescone, Ralph Barbosa Vendramini-Costa, Débora Franco-Barraza, Janusz Wagner, Jessica Muir, Alexander Lau, Allison N. Gabitova, Linara Pazina, Tatiana Gupta, Sapna Luong, Tiffany Rollins, Dustin Malik, Ruchi Thapa, Roshan J. Restifo, Diana Zhou, Yan Cai, Kathy Q. Hensley, Harvey H. Tan, Yinfei Kruger, Warren D. Devarajan, Karthik Balachandran, Siddharth Klein-Szanto, Andres J. Wang, Huamin El-Deiry, Wafik S. Vander Heiden, Matthew G. Peri, Suraj Campbell, Kerry S. Astsaturov, Igor Cukierman, Edna Koch Institute for Integrative Cancer Research at MIT Massachusetts Institute of Technology. Department of Biology © 2020 American Association for Cancer Research. Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate and lacks effective therapeutics. Therefore, it is of paramount importance to identify new targets. Using multiplex data from patient tissue, three-dimensional coculturing in vitro assays, and orthotopic murine models, we identified Netrin G1 (NetG1) as a promoter of PDAC tumorigenesis. We found that NetG1+ cancer-associated fibroblasts (CAF) support PDAC survival, through a NetG1-mediated effect on glutamate/glutamine metabolism. Also, NetG1+ CAFs are intrinsically immunosup-pressive and inhibit natural killer cell–mediated killing of tumor cells. These protumor functions are controlled by a signaling circuit downstream of NetG1, which is comprised of AKT/4E-BP1, p38/FRA1, vesicular glutamate transporter 1, and glutamine synthetase. Finally, blocking NetG1 with a neutral-izing antibody stunts in vivo tumorigenesis, suggesting NetG1 as potential target in PDAC. SIGNIFICANCE: This study demonstrates the feasibility of targeting a fibroblastic protein, NetG1, which can limit PDAC tumorigenesis in vivo by reverting the protumorigenic properties of CAFs. Moreover, inhibition of metabolic proteins in CAFs altered their immunosuppressive capacity, linking metabolism with immunomodulatory function. 2022-02-10T22:55:04Z 2021-10-27T20:30:44Z 2022-02-10T22:55:04Z 2020-10 2020-09 2021-08-03T16:48:29Z Article http://purl.org/eprint/type/JournalArticle 2159-8274 2159-8290 https://hdl.handle.net/1721.1/136086.2 en http://dx.doi.org/10.1158/2159-8290.cd-20-0775 Cancer Discovery Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/octet-stream American Association for Cancer Research (AACR) PMC
spellingShingle Francescone, Ralph
Barbosa Vendramini-Costa, Débora
Franco-Barraza, Janusz
Wagner, Jessica
Muir, Alexander
Lau, Allison N.
Gabitova, Linara
Pazina, Tatiana
Gupta, Sapna
Luong, Tiffany
Rollins, Dustin
Malik, Ruchi
Thapa, Roshan J.
Restifo, Diana
Zhou, Yan
Cai, Kathy Q.
Hensley, Harvey H.
Tan, Yinfei
Kruger, Warren D.
Devarajan, Karthik
Balachandran, Siddharth
Klein-Szanto, Andres J.
Wang, Huamin
El-Deiry, Wafik S.
Vander Heiden, Matthew G.
Peri, Suraj
Campbell, Kerry S.
Astsaturov, Igor
Cukierman, Edna
Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
title Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
title_full Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
title_fullStr Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
title_full_unstemmed Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
title_short Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
title_sort netrin g1 promotes pancreatic tumorigenesis through cancer associated fibroblast driven nutritional support and immunosuppression
url https://hdl.handle.net/1721.1/136086.2
work_keys_str_mv AT francesconeralph netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT barbosavendraminicostadebora netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT francobarrazajanusz netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT wagnerjessica netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT muiralexander netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT lauallisonn netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT gabitovalinara netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT pazinatatiana netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT guptasapna netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT luongtiffany netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT rollinsdustin netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT malikruchi netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT thaparoshanj netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT restifodiana netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT zhouyan netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT caikathyq netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT hensleyharveyh netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT tanyinfei netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT krugerwarrend netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT devarajankarthik netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT balachandransiddharth netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT kleinszantoandresj netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT wanghuamin netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT eldeirywafiks netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT vanderheidenmatthewg netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT perisuraj netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT campbellkerrys netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT astsaturovigor netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression
AT cukiermanedna netring1promotespancreatictumorigenesisthroughcancerassociatedfibroblastdrivennutritionalsupportandimmunosuppression